References
- Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.STR.24.1.35
- Centers for Disease Control and Prevention. Underlying cause of death, 1999–2018. CDC WONDER online database. Centers for Disease Control and Prevention; 2018.
- Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics—2022 update: a report from the American heart association external icon. Circulation. 2022;145(8):e153–e639. doi:10.1161/CIR.0000000000001052
- Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683–690. doi:10.1001/jamaneurol.2020.1127
- Ellul M, Benjamin L, Singh B, et al. Neurological associations of COVID-19. [published online ahead of print, 2020 Jul 2]. Lancet Neurol. 2020:30221. doi:10.1016/S1474-4422(20)30221-0
- Romero-Sánchez C, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. [published online ahead of print, 2020 Jun 1]. Neurology. 2020;95(8):e1060–e1070. doi:10.1212/WNL.0000000000009937
- Qureshi AI, Abd-Allah F, Alsenani F, et al. Management of acute ischemic stroke in patients with COVID-19 infection: report of an international panel. [published online ahead of print, 2020 Jun 22]. Int J Stroke. 2020:1747493020935396. doi:10.1177/17474930209353966
- Ntaios G, Michel P, Georgiopoulos G, et al. Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the global COVID-19 stroke registry. [published online ahead of print, 2020 Jul 9]. Stroke. 2020. doi:10.1161/STROKEAHA.120.031208
- Siegler JE, Cardona P, Arenillas JF, et al. EXPRESS: cerebrovascular events and outcomes in hospitalized patients with COVID-19: the SVIN COVID-19 multinational registry. Int J Stroke. 2020. doi:10.1177/1747493020959216
- Harris S, Sungkar S, Rasyid A, Kurniawan M, Mesiano T, Hidayat R. TOAST subtypes of ischemic stroke and its risk factors: a hospital-based study at Cipto Mangunkusumo Hospital, Indonesia. Stroke Res Treat. 2018;2018:1–6. doi:10.1155/2018/9589831
- Grau AJ, Weimar C, Buggle F, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001;32(11):2559–2566. doi:10.1161/hs1101.098524
- F¨orster A, Gass A, Kern R, et al. Gender differences in acute ischemic stroke etiology, stroke patterns and response to thrombolysis. Stroke. 2009;40(7):2428–2432. doi:10.1161/STROKEAHA.109.548750
- Yu C, An Z, Zhao W, et al. Sex differences in stroke subtypes, severity, risk factors, and outcomes among elderly patients with acute ischemic stroke. Front Aging Neurosci. 2015;7. doi:10.3389/fnagi.2015.00174
- Turin TC, Kita Y, Rumana N, et al. Ischemic stroke subtypes in a Japanese population: Takashima Stroke Registry, 1988–2004. Stroke. 2010;41(9):1871–1876. doi:10.1161/STROKEAHA.110.581033
- Al-Hashel JY, Al-Sabah -A-A, Ahmed SF, et al. Risk factors, subtypes, and outcome of ischemic stroke in Kuwait: a national study. J Stroke Cerebrovasc Dis. 2016;25(9):2145–2152. doi:10.1016/j.jstrokecerebrovasdis.2016.05.038
- Ortega-Gutierrez S, Farooqui M, Zha A, et al. Decline in mild stroke presentations and intravenous thrombolysis during the COVID-19 pandemic: the Society of Vascular and Interventional Neurology Multicenter Collaboration [published online ahead of print, 2020 Dec 15]. Clin Neurol Neurosurg. 2020;201:106436. doi:10.1016/j.clineuro.2020.106436
- Porcello Marrone LC, Diogo LP, de Oliveira FM, et al. Risk factors among stroke subtypes in Brazil. J Stroke Cerebrovasc Dis. 2013;22(1):32–35. doi:10.1016/j.jstrokecerebrovasdis.2011.05.022
- Bahou Y, Ajour M, Jaber M. Ischemic stroke at Jordan University Hospital: a one-year hospital-based study of subtypes and risk factors. SM J Neurol Neurosci. 2015;1(1):1003.
- Hisham NF, Bayraktutan U. Epidemiology, pathophysiology, and treatment of hypertension in ischaemic stroke patients. J Stroke Cerebrovasc Dis. 2013;22(7):e4–e14. doi:10.1016/j.jstrokecerebrovasdis.2012.05.001
- Shah SP, Shrestha A, Pandey SR, et al. Dyslipidemia in Acute Non-cardioembolic Ischemic Stroke Patients at a Tertiary Care Centre: a Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2022;60(247):241–245. doi:10.31729/jnma.7321
- Yaghi S, Elkind MSV. Lipids and Cerebrovascular Disease. Stroke. 2015;46(11):3322–3328. doi:10.1161/strokeaha.115.0111
- Ramos-Araque ME, Siegler JE, Ribo M, Requena M, López C, Vazquez AR. Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry. BMC Neurol. 2021;21(1). doi:10.1186/s12883-021-02075-1
- Shahjouei S, Tsicgoulis G, Farahmand G, et al. SARS-CoV-2 and Stroke Characteristics A Report From the Multinational COVID-19 Stroke Study Group. Stroke. 2021;52:e117–e130. doi:10.1161/STROKEAHA.120.032927
- Tunç A, Ünlübaş Y, Alemdar M, et al. Coexistence of COVID-19 and acute ischemic stroke report of four cases. J Clin Neurosci. 2020;77:227–229. doi:10.1016/j.jocn.2020.05.018
- Reddy ST, Garg T, Shah C, et al. Cerebrovascular disease in patients with COVID-19: a review of the literature and case series. Case Rep Neurol. 2020;12:199–209. doi:10.1159/000508958
- Getu S, Tiruneh T, Andualem H, et al. Coagulopathy in SARS-CoV-2 infected patients: implication for the management of COVID 19. J Blood Med. 2021;12:635–643. doi:10.2147/JBM.S304783
- Yazdanpanah F, Hamblin MR, Rezaei N. The immune system and COVID-19: friend or foe? Life Sci. 2020;256:117900. doi:10.1016/j.lfs.2020.117900
- Tang N, Bai H, Chen X, Gong J, Dengju L, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–1099. doi:10.1111/jth.14817
- Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. doi:10.1007/s00134-020-06062-x
- Guan W-J, Zheng-yi N, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
- Kim Y, Khose S, Abdelkhaleq R, Salazar-Marioni S, Zhang G-Q, Sheth SA. Predicting In-hospital mortality using D-Dimer in COVID-19 patients with acute ischemic stroke. Front Neurol. 2021;12:702927. doi:10.3389/fneur.2021.702927
- Bhatia R, Radhakrishna P, Komakula S, et al. Stroke in coronavirus disease 2019: a systematic review. J Stroke. 2020;22(3):324–335. doi:10.5853/jos.2020.02264
- Amalia L. Hypercoagulable state induced spinal cord stroke after coronavirus disease 19 infection. J Blood Med. 2021;12:1057–1060. doi:10.2147/JBM.S329449